BioLineRx Ltd. (BLRX)
3.17
-0.06
(-1.86%)
USD |
NASDAQ |
Dec 12, 15:53
BioLineRx Shareholders Equity (Quarterly): 19.53M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd. | 43.83M |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | 10.49M |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.80M |
| Total Liabilities (Quarterly) | 20.27M |
| Debt to Equity Ratio | 0.5825 |
| Current Ratio | 2.087 |
| Net Debt Paydown Yield | 24.17% |